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RÉSUMÉ (IN FRENCH) 
Elucider les bases moléculaires et cellulaires du fonctionnement des cellules souches 
s'avère crucial dans la compréhension de l'organisation cellulaire au sein des tissus et des 
organes ainsi que pour le développement de nouvelles stratégies thérapeutiques en 
médecine régénérative et en oncologie. Les cellules souches adultes les mieux connues 
sont celles responsables de l'hématopoïèse, les cellules souches hématopoïétiques 
(CSH). Durant ces dernières années, la recherche a porté une attention particulière à 
l'isolation prospective de CSH dérivées de la moelle osseuse de souris en utilisant des 
marqueurs de surface cellulaire ainsi que des propriétés fonctionnelles alléguées. Par la 
suite, la capacité fonctionnelle des CSH a été vérifiée classiquement par leur 
transplantation intraveineuse dans des souris réceptrices conditionnées et par l'analyse de 
leur aptitude à reconstituer le système hématopoïétique à long terme. Des études 
récentes suggèrent que la transplantation des cellules directement dans la moelle osseuse 
pourrait non seulement aboutir à une prise de greffe plus rapide et plus efficace, mais 
pourrait même aider à l'identification de cellules qui ont certes des propriétés intrinsèques 
de CSH, mais qui n'ont pas la capacité de trouver leur niche au sein de la moelle osseuse 
et ont donc échoué dans les analyses classiques de reconstitution. Dans cette étude, nous 
comparons à deux niveaux la fonction de différents sous-groupes de cellules souches de 
la moelle osseuse, définis par leur phénotype de surface cellulaire. Premièrement, nous 
étudions leur capacité à reconstituer des souris !étalement irradiées après injection soit 
intraveineuse soit intrafémorale. Deuxièmement, par analyse cytométrique de flux à 8 
couleurs, nous comparons leur activité relative de « side population » (SP) par exclusion 
du colorant fluorescent Hoechst 33342. Nos résultats préliminaires renforcent en effet 
l'idée que la transplantation intrafémorale aboutit à une greffe plus rapide et plus efficace. 
Par contre, en utilisant cette approche, nous n'arrivons pas à identifier des cellules 
capables de prendre greffe spécifiquement quand elles sont injectées en intrafémorale. 
Finalement, bien qu'une confirmation in vivo soit encore nécessaire, nous suggérons sur 
la base de nos analyses cytométriques de flux, que les cellules SP Sca1 très élevé CD48très bas 
sont très enrichies en CSH. Ceci permettrait l'isolation ex vivo de CSH de la moelle 
osseuse de souris par une stratégie à la fois nouvelle et simple. 
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SUMMARY 
Elucidating the molecular and cellular bases of stem cell function is crucial for the 
understanding of cellular organisation within tissues and organs as well as for the 
development of new therapeutic strategies in regenerative medicine and oncology. The 
best-known adult stem cells are those responsible for haematopoiesis, the haematopoietic 
stem cells (HSCs). ln recent years, much effort has been put into the prospective isolation 
of mouse bone marrow (BM)-derived HSCs using cell-surface markers and alleged 
functional properties. Upon isolation, the functional capacity of putative HSCs has been 
classically assessed by intravenous transplantation into conditioned recipient mice and 
analysis of their ability to reconstitute the haematopoietic system at long-term. lt has 
recently been suggested that transplanting the cells directly into the BM might not only 
result in more rapid and more effective engraftment, but even help to identify cells that 
have intrinsic HSC properties but lack the ability to home to their BM niche and have thus 
failed to succeed in classical reconstitution assays. ln this study, we compare the function 
of different BM cell subsets, as defined by their cell surface phenotype, on two levels. 
Firstly, we assess their ability to reconstitute lethally irradiated mice, when injected either 
intravenously or intrafemorally. Secondly, using 8-colour flow cytometric analysis, we 
compare their relative side population (SP) activity by exclusion of the fluorescent dye 
Hoechst 33342. Our preliminary results indeed reinforce the idea that intrafemoral 
transplantation results in faster and more effective engraftment, however, using this 
approach, we are unable to identify cells that are capable of engrafting specifically when 
injected intrafemorally. Finally, although in vivo confirmation is still required, we propose, 
based on the results of our flow cytometric analyses, that SP Sca1very high CD48very low cells 
should be highly enriched for HSCs. This would allow for a simple new strategy for the 
isolation of mouse BM HSCs ex vivo. 
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PRELIMINARY REMARKS 
Having been accepted to the Swiss MD-PhD programme in May 2006, 1 graduated from 
the University of Lausanne (UNIL) medical school six months later and started my MD-
PhD thesis in the laboratory of Prof. Andreas Trumpp at the Swiss lnstitute for 
Experimental Cancer Research (ISREC) and the Swiss Federal lnstitute of Technology 
Lausanne (EPFL) in March 2007. 
ln January 2008, Prof. Trumpp announced his appointment as the head of the Division of 
Cell Biology at the German Cancer Research Centre (DKFZ) in Heidelberg and, related to 
this, the upcoming move of his laboratory from Lausanne to Heidelberg. With the backing 
of the Swiss MD-PhD programme, the Swiss Academy for Medical Sciences as well as of 
my funding agency, the Swiss National Science Foundation, 1 consequently decided to 
change my hast laboratory and research project. Since March 2008, 1 have thus been 
working as a PhD student in the laboratory of Dr. Claus Azzalin under the supervision of 
Prof. Ulrike Kutay at the Swiss Federal lnstitute of Technology Zurich. 
As the Zurich MD-PhD programme, in contrast to the one in Lausanne, requires its 
students to apply for an MD degree in addition to and separately from the PhD degree, 1 
decided to write up my MD thesis on the basis of the results 1 had obtained from my 
experimental work in the laboratory of Prof. Trumpp at ISREC / EPFL. Prof. Ivan 
Stamenkovic of UNIL's lnstitute of Pathology kindly agreed to serve as my official thesis 
director for this purpose. Furthermore, this endeavour carries the approval of Prof. Amalio 
Telenti and Prof. Adriano Aguzzi, presidents of the Lausanne and Zurich MD-PhD 
programme committees, respectively, as well as of Prof. Stephanie Clarke, director of the 
doctoral school of UNIL's Faculty of Biology and Medicine. 
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INTRODUCTION 
Stem Cells and Architecture of Self-Renewing Tissues 
Stem cells, traditionally subdivided into two categories, embryonic and adult stem cells, 1 
hold great promise for the development of new therapeutic strategies in regenerative 
medicine and oncology. 1 2 Embryonic stem cells are pluripotent cells that derive from the 
inner cell mass of the blastocyst and are capable of generating all differentiated cell types 
of the body, including adult stem cells. 1 The latter, in contrast, have restricted pluripotency 
and usually differentiate only into cell types specific for the organ or tissue they reside in, 
although some degrees of plasticity seem to exist. 1 
Adult stem cells are per se critical for lite-long host tissue maintenance and repair after 
injury.1 Although they have been described in most (and even low cell-turnover) tissues, 
they remain best characterised in the "classical" self-renewing tissues, namely the 
haematopoietic system, the small intestine and the epidermis. 3 
Cells within these tissues are organised in a hierarchical manner (Figure 1 ). 3 Stem cells, 
on the uppermost level, are rare pluripotent cells, which are long-lived and capable of self-
renewal. Their interaction with the surrounding microenvironment, the so-called stem cell 
niche, contrais their homeostasis and determines their fate (quiescence, self-renewal, or 
differentiation). While thought to remain quiescent under homeostatic conditions, stem 
cells are capable of extensive proliferation upon activation. They may divide either 
symmetrically, giving rise to two stem cells or to two more differentiated cells, or 
asymmetrically, generating one of either. When their offspring undergoes a commitment to 
differentiate, it first enters the so-called transit-amplifying phase, during which the cells 
rapidly proliferate.3 Upon exhaustion of their proliferative potential, these multipotent cells 
withdraw from their self-renewal cycle and execute a terminal differentiation programme. 
Differentiated cells generally have specific characteristic functions, a short lite span, and 
they cannot self-renew.3 
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Figure 1. Madel illustrating the hypothetical 
hierarchical organisation of cells in self-
renewing tissues . See text for further details. 
HSCs and Long-Term Repopulating Assays 
The most frequently investigated stem cells are those responsible for replenishing the 
haematopoietic system, the haematopoietic stem cells (HSCs).4 ln tact, most of the 
conceptual paradigms and experimental strategies that are pertinent to stem cells in 
general were first defined in this system.5 HSCs are cells that have the potential to self-
renew and differentiate into all mature blood cell lineages. They are located in the bone 
marrow (BM) during homeostasis, but can be mobilised to the spleen and liver after BM 
injury.6 7 ln the BM of an adult mouse, they represent on the order of 1 in 104 to 105 cells.8 
HSC activity within the BM has been extensively studied ever since 1956, when it was first 
shown that lethally irradiated recipients could be durably reconstituted by transplantation of 
total BM from healthy mice.9 These early experiments not only suggested that transplanted 
BM contains cells that are able to clonally differentiate into multiple lineages while self-
renewing, but they also formed the basis for what has turned out to establish itself as the 
gold standard assay to prove enrichment for HSC activity. Although the functional capacity 
of putative HSCs can also be assessed using in vitro assays (such as long-term culture-
initiating cell or cobblestone area-forming cell assays) or other in vivo assays (such as 
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spleen colony assays),4 it is the long-term repopulating (L TR) assays that have become 
the defining element, the sine qua non, of HSC activity. They are based on the capacity of 
transplanted HSCs to act as long-term reconstituting cells by durably repopulating the 
entire haematopoietic system in conditioned recipients.4 The strictest version of L TR 
assays is known as serial transplantation and requires that HSC-containing donor BM can 
be re-transplanted from the primary recipient into secondary (and even tertiary) recipients 
while retaining bath self-renewal and multilineage differentiation capacity. 10 
L TR assays have been classically performed using intravenous (IV) injection of putative 
HSCs, entailing the necessity for them to circulate through blood, recognise and 
extravasate through BM vasculature and to migrate to a supportive microenvironment, 
before reconstitution can occur. This awareness recently led to the suggestion that direct 
injection of the cells into the BM cavity, for example, by intrafemoral (IF) injection, might 
not only accelerate engraftment but might even help to identify cells that have intrinsic 
repopulating activities but are unable to home to the BM.1112 
Although technically challenging, several groups recently succeeded at performing L TR 
assays even at the single-cell level, achieving long-term haematopoietic reconstitution of 
lethally irradiated mice by transplantation of a single, previously purified, BM HSC, thus 
formally proving the existence of bona fide somatic adult stem cells. 13-19 
Enrichment for HSC Activity using Cell Surface Markers 
Over the past few decades, considerable efforts have been made in bath human and 
mouse to determine exactly which cell types constitute the HSC compartment. Most recent 
approaches to purify putative HSCs, or, more precisely, to enrich for putative HSC activity, 
have used fluorescence-activated cell sorting (FACS) and are based on the level of 
expression of a combination of cell surface markers. 
The highest single-cell long-term reconstitution efficiency (47%) in mice has so far been 
reported for BM cells with the following combined antigenic marker phenotype: 16 20 1. Lin-, 
absence (or low abundance) of cell-surface markers normally present on lineage-
committed haematopoietic cells; 2. Sca1+, high-level surface expression of stem-cell 
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antigen-1; 3. cKit+, high-level surface expression of c-Kit receptor; 4. CD48-, low-level 
surface expression of SLAM receptor CD48; 5. CD150+, high-level surface expression of 
the signal activating molecule (SLAM) receptor CD150. 
Simultaneously, it has been reported that all long-term reconstitution activity of lineage-
depleted adult mouse BM is retained within the Lin- Sca1 + cKit+ (LSK) fraction that shows 
no or low expression of the antiadhesive sialomucin CD34 (CD34-), although the single-
cell reconstitution efficiency of ce lis with this phenotype is lower (22%) than that for the 
phenotype described above. 13 20 
Recent experimental evidence, involving an assessment of the degree of HSC quiescence 
by bromodeoxyuridine (BrdU) label-retaining assays in addition to cell surface staining, 
now indeed suggests that the LSK CD48- CD150+ CD34- fraction of BM cells represents 
the most dormant HSC population (Wilson and Trumpp, unpublished data). Moreover, the 
observation that CD34- cells are only found in the LSK CD48- CD150+ subset, provokes 
the idea that the acquisition of CD34 surface expression in LSK CD48- CD150+ BM cells 
may be one of the determining events in the transition from dormant to actively self-
renewing adult HSCs.20 On the basis of these and other observations, LSK CD48- CD150+ 
BM cells have been hypothetically subdivided into dormant (CD34-) and activated (CD34+) 
HSCs.20-22 Furthermore, based on the expression of these antigenic markers, a hierarchy 
of BM stem and transit amplifying cell subsets has been proposed, starting with LSK 
CD48- CD150+ co34- cells and leading, via the sequential acquisition of CD34 and CD48, 
followed by the loss of CD150, to LSK CD48+ CD150- CD34+ cells. 20 
Enrichment for HSC Activity using the Side Population Phenotype 
An alternative approach to enrich for putative HSC activity also uses flow cytometry, but is 
based on alleged physiologie properties of HSCs such as an elevated activity of aldehyde 
dehydrogenase or an increased ability to efflux the fluorescent DNA-binding dye Hoechst 
33342.23-26 This latter feature is essentially due to an increased activity in HSCs of the 
ATP-binding-cassette transporter ABCG2, a multidrug resistance (MDR)-related protein, 
also known as breast cancer resistance protein (BCRP).27 Display of Hoechst 33342 
fluorescence simultaneously at two different emission wavelengths thus allows for 
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identification of a cell fraction known as the side population (SP), which accounts for 
0.07% to 0.10% of mouse BM cells and represents a 2000-fold enrichment for long-term 
reconstituting cells.24 
The SP technique has not only proven useful for the prospective isolation of HSCs, but 
has, in tact, been a big boost to the stem cell field in general, as it has been used to purify 
stem cell-like subsets from different organisms, tissues, and developmental states.28-31 
Moreover, dye exclusion has been invaluable even for cancer research, as it has allowed 
for cancer stem cell enrichment from various types of cancers. 32 
More recently, the SP phenotype has been suggested to be a marker of quiescence, 33 34 
and innumerable studies have not only addressed the relationship between SP cells and 
HSCs isolated on the basis of cell surface markers, but have actually used a combination 
of bath strategies to efficiently enrich for HSC activity.17 26 33-35 
Design and Aim of Project 
The aim of this project is to compare functional properties of different HSC subsets. More 
specifically, we would first like to confirm that mouse LSK CD48- CD150+ co34- BM cells, 
sorted by fluorescence-activated cell sorting (FACS), are capable of long-term 
reconstitution (as assessed by long-term analysis of peripheral donor granulocyte 
frequencies), no matter whether injected IV or IF into lethally irradiated mice. Secondly, we 
would like to test whether LSK CD48- CD150+ CD34+ BM cells contain sub-populations 
which are capable of long-term reconstitution when injected IF (and not when injected IV), 
the hypothesis being that the presence of CD34 surface expression may hamper homing 
of HSCs to BM but not necessarily interfere with their intrinsic ability to engraft and 
reconstitute. Furthermore, using 8-colour flow cytometric analysis, we will directly compare 
the phenotype of HSCs, based on their expression of the above-mentioned antigenic 
markers, with their SP-forming capacity. 
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MATERIALS & METHODS 
Mi ce 
Ali mice were housed under specific pathogen-free (SPF) conditions in individually 
ventilated cages at the ISREC core animal facility. Animal procedures were performed in 
accordance with the Swiss federal veterinary office (authorisation number: 1728). For the 
LTR assays, female C57BL/6J (CD45.2) mice (Harlan Europe) aged 12-16 weeks were 
used as recipients as well as for preparation of rescue BM, whereas male SJL-Ptprca 
Pep3b/BoyJ (CD45.1) mice (Charles River Laboratories) aged around 20 weeks were 
used as donors. For the comparison of HSC surface markers with the side population 
phenotype, male or female C57BL/6J mice aged 13 weeks were used. 
Preparation of Bone Marrow Single Cell Suspension 
To retrieve BM, the long bones of hind- and forelegs (and, in the case of donor BM 
preparation, the vertebral column) were crushed in Roswell Park Memorial lnstitute-1640 
medium with GlutaMAX (RPMI) (lnvitrogen) supplemented with 2% foetal calf serum (FCS) 
(lnvitrogen) using a pestle and mortar. Supernatants were filtered through a 35µm nylon 
mesh (BD Biosciences) prior to further use in order to prevent clumps. 
Lineage Depletion of Total Bone Marrow Cells 
For preparation of un- BM, cells were first stained (see below) with a cocktail of biotin-
conjugated mouse antibodies against lineage markers (CD4, CDS, 8220, Ter119, CD11 b, 
and Gr1) (homemade hybridomas) in phosphate buffered saline (PBS) (Sigma) 
supplemented with 2% FCS and in the presence of 24G2 (see below). After washing with 
RPMI / 2% FCS, the labelled cells were removed with the help of Dynabeads coated with a 
polyclonal sheep anti-rat lgG antibody (lnvitrogen) according to the manufacturer's 
instructions (Dynal mouse CD4 negative isolation kit). A bead-to-cell ratio of 4:1 to 5:1 was 
used, assuming a target frequency of 90%. The supernatant was collected and washed 
with RPMI / 2% FCS prior to further use. 
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Hoechst 33342 Staining prior to Flow Cytometry 
BM cells were centrifuged and re-suspended at 1 million cells per ml in Dulbecco's 
modified Eagle's medium with GlutaMAX and 4.5g/l D-glucose (DMEM) (lnvitrogen) 
supplemented with 2% FCS and 10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
butter (HEPES) (lnvitrogen), prewarmed to 37°C. Hoechst 33342 (Hoechst) (lnvitrogen) 
was added at a concentration of 4µg/ml, and, in addition, verapamil (Sigma-Aldrich) was 
added to the negative contrai at 50µM.24 The cells were incubated at 37°C for 90 minutes, 
and agitated every 20-30 minutes during incubation. Subsequently, cells were centrifuged 
and re-suspended in ice-cold Hank's balanced sait solution without Mg2+, Ca2+ and phenol 
red (HBSS) (lnvitrogen) supplemented with 2% FCS and 1 OmM HEPES. Optionally, cells 
were additionally stained with antibodies as described below, with the exception that cold 
HBSS (supplemented as above) was used instead of PBS / 2% FCS. ln any case, from 
now on, cells were kept on ice and protected tram light until FACS analysis. 
Antibody Staining prior to Flow Cytometry 
BM cells were centrifuged and re-suspended at 30 million cells per ml of PBS / 2% FCS in 
the presence of 24G2 hybridoma supernatant containing a monoclonal anti-mouse FcR 
antibody, thus preventing FcR-mediated binding of the other antibodies. The following 
antibody-fluorochrome conjugates were used for staining: PECy7-conjugated anti-lineage 
marker antibodies, Sca1-Alexa700, cKit-APC-Alexa750, CD48-PE, CD34-FITC (ail from 
eBioscience), and CD150-PECy5 (Biolegend). Unstained and single-stained samples 
were prepared in parallel as compensation contrais. Staining was performed by incubating 
the cells on ice with the appropriate antibodies for 30 minutes. labelled cells were washed 
with PBS / 2% FCS, re-suspended in appropriate volumes of the same butter and stored 
on ice and in the dark until analysis. 
Flow Cytometry 
Multicolour analysis in the presence of Hoechst 33342 was performed on a FACS Vantage 
flow cytometer (BD Biosciences) equipped with 350nm (UV), 488nm and 647nm lasers. 
Propidium iodide (Pl) (Sigma-Aldrich) was added to ail samples containing Hoechst 33342, 
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enabling subsequent identification and exclusion of dead cells by appropriate gating on the 
Hoechst plot during analysis, as Pl+ cells give an extraordinary high signal on the Hoechst 
red axis. Ali cell suspensions were filtered through a 35µm nylon mesh immediately before 
analysis. Compensation settings were adjusted with the help of unstained and single-
stained samples. Ali post-acquisition analysis of FACS data (including post-acquisition 
adjustment of compensation settings) was performed using FlowJo software (Tree Star 
1 ncorporation ). 
Long-Term Repopulating (LTR) Assays 
Recipient mice were injected intra-peritoneally with 1 OOµg of PK136 (anti-CD161 c) 
antibody (grown and purified in our laboratory) 48h prior to injection of donor BM to 
minimise host-versus-graft disease.37 They were lethally irradiated (1x1OOOrad)24h later in 
order to create favourable conditions for HSC homing and engraftment.38-4° For the first 7 
days after total body irradiation (TBI), the drinking water was supplemented with co-
trimoxazole (Roche) and paracetamol/acetaminophen (Bristol-Myers Squibb / UPSA). For 
the subsequent 14 days, the water was supplemented with co-trimoxazole only. During 
this time, water bottles were changed twice a week. 
A un- donor BM single cell suspension (from 2-4 mice per experiment) was prepared and 
antibody-stained as described above. LSK CD48- CD150+ and either CD34+ or co34- as 
well as LSK CD48+ co1so- CD34+ cells (the latter for a negative contrai that was only 
done during the first experiment)20 were sorted with a FACS Vantage and collected in 
homemade sterile medium consisting of StemPR0-34 serum-free medium (lnvitrogen) 
supplemented with StemPR0-34 nutrient (lnvitrogen), mouse stem cell factor, 
thrombopoietin, Flt-3 ligand, IL-11 (all from R&D Systems), penicillin/streptomycin, L-
glutamine (both from lnvitrogen) and ciprofloxacin (Bayer).41 -43 After cell counting and 
centrifugation, appropriate numbers of cells were re-suspended in either 300 or 25µL of 
non-supplemented PBS, for IV and IF injections, respectively. 
Whereas IV injections were performed as usual via one of the tail veins, IF injections were 
done as follows. 2h prior to injection, mice were injected subcutaneously with the patent 
opioid analgesic buprenorphine (ESSEX Chemie AG). The mice were anaesthesised using 
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a diluted mix of ketamine (Dr. E. Graeub AG) and xylazine (Bayer). Ali following 
procedures were performed on a heating pad in order to keep the mouse warm. To 
prevent them from drying, the corneas of the eyes were covered with the ophthalmic gel 
Lacryvisc (Alcon). With the (previously shaved) knee bent, a hole was made into the distal 
femur using an 18G needle. The needle was removed and replaced with a 26G needle 
fixed to a syringe containing the cells to be injected. Upon injection, the needle was 
removed, and the wound disinfected with liquid Betadine (Mundipharma) and gently 
rubbed with the ointment Cicatrex (Pfizer). The mouse cages were left on heating pads for 
at least 12h post-injection to faveur recovery. 
24-48h later, rescue BM was prepared by putatively depleting total BM (prepared as 
above) of HSCs using the rat anti-mouse anti-Sca1-PECy5 antibody and the Dynabead 
system described above with a bead-to-cell ratio of 4:1 to 5:1 and assuming a target 
frequency of 10%. 1 million cells were injected IV as rescue BM. The following 
modifications of this protocol were undertaken during the second experiment (see below). 
Prier to HSC depletion, total BM was first depleted of T cells using complement-mediated 
cytotoxicity; after an initial 30-minute incubation step on ice with AT83 supernatant 
(homemade hybridoma), which contains rabbit anti-mouse anti-Thy1 .2 antibodies, rabbit 
complement (Saxon Europe Ltd.) and DNAse (Roche) were added and the cells were 
incubated for an additional 30 minutes at 37°C. HSC depletion was performed with beads 
assuming a target frequency of 50%, and only 400'000 cells were injected. 
The mice were hereafter regularly checked for survival, and the extent of reconstitution 
was examined by biweekly analysis of peripheral white blood cell (WBC) and granulocyte 
chimerism between weeks 4 and 12 post-transplantation. Briefly, 5-8 drops of blood were 
collected in tubes containing PBS and heparin (Sigma) by tail-vein bleeding. The cell 
suspension was underlayed with Histopaque (Sigma) and centrifuged. Peripheral WBCs 
were harvested from the interface, washed and stained (as described above) with the 
following antibody conjugates: CD45.1-FITC, CD45.2-PECy5.5, and Gr1-PE (all from 
eBioscience). The labelled cells were analysed (similar to above) on a FACS Sean flow 
cytometer, and post-acquisition analysis of the FACS data was again performed using 
FlowJo software. 
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RESULTS 
Long-Term Reconstitution Ability of Different HSC Subsets 
To examine the long-term reconstitution ability of LSK CD48- CD150+ BM cells that are 
either CD34+ or CD34-, long-term L TR assays were performed in two separate 
experiments. CD45.1 donor cells were sorted according to their antigenic marker profile 
(see below for an illustration of the gating strategy) and injected either IV or IF into 
previously lethally irradiated CD45.2 recipient mice (Table 1 ). ln order to prevent short-
and midterm death, all mice were injected with HSC-depleted CD45.2 rescue BM 24-48 
hours after HSC injection. 
1 st experiment 2na experiment 
LSK CD48- CD150+ co34- 15 cells 5 mice 15 cells 7 mice 
LSK CD48- CD1 so+ CD34+ 15 cells 5 mice 45 cells 5 mice 
LSK CD48+ co1so- CD34+ 15 cells 3 mice - -
(Negative Control) 
Table 1. Overview of cell and mouse numbers used for both reconstitution 
experiments. The same number of mice was injected with the same number of 
cells both IV and IF! See text for further details. 
Despite the administration of rescue BM, a number of deaths occurred within the first 15 
days after transplantation (Table 2). The analyses below are thus based on the remaining 
(surviving) mice only. To our surprise, despite the documented absence of long-term HSC 
activity within the LSK CD48+ CD150- CD34+ subgroup, no deaths were observed among 
the control-injected mice, neither at short- nor at long-term (Table 2), suggesting, taking 
into account the absence of engraftment (see below), either inefficient total body irradiation 
or inefficient HSC depletion of the rescue BM. 
The long-term reconstitution ability of the transplanted cells was assessed by measuring 
the frequencies of peripheral donor (CD45.1) granulocytes biweekly from week 4 to at 
least 12 weeks post-transplantation. Peripheral granulocyte chimerism has been shown to 
reflect much more accurately HSC chimerism than the overall donor contribution in the 
blood.44 Figure 2 illustrates an example of such an analysis. 
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1 st experiment 2nd experiment 
IV IF IV IF 
LSK CD48- CD150+ co34- 1/5 (20%) 015 (0%) 1/7 (14%) 1/7 (14%) 
LSK CD48- CD150+ CD34+ 015 (0%) 2/5 (40%) 0/5 (0%) 3/5 (60%) 
LSK CD48+ co1so- CD34+ 0/3 (0%) 0/3 (0%) - -
(Negative Control) 
Table 2. Summary of deaths that occurred after HSC injection in each experimental group. 
Percentages express relative numbers, taking into account the total number of mice used in 
each experimental group (see Table 1 ). 
ln the first experiment, as expected, no chimerism was observed in the LSK CD48+ 
CD150- CD34+ (negative contrai) cell-engrafted mice (data not shown), suggesting that 
these cells are indeed unable to engraft. ln tact, only mice transplanted with LSK CD48-
CD150+ co34- cells showed chimerism, namely, 2 (50%) of the 4 surviving IV-injected 
and 3 (60%) of the 5 surviving IF-injected mi ce. The average frequency of CD45.1 + 
granulocytes rose faster and was more elevated at all times in the IF-injected subgroup 
(Figure 3), suggesting that intra-BM transplantation of HSCs results in more rapid and 
more efficient engraftment. The difference, however, between the IV- and IF-injected 
subgroups was minimal at an analysis undertaken at 27 weeks post-transplantation, 
mainly because one mouse in the IF-injected subgroup displayed diminishing chimerism 
over time (Figure 3). No evidence of engraftment could be shown for the LSK CD48-
CD150+ CD34+ cells, neither, as expected, for those injected IV, nor, however, for those 
injected IF. 
Taking into account the rather high variability and error bars within the first experiment 
(Figure 3) and in order to confirm these preliminary findings, a second experiment was 
undertaken. ln order to try to decrease variability, the number of mice transplanted with 
LSK CD48- CD150+ CD34- cells was increased from 5 to 7, and, in order to test whether 
transplantation of an increased number of LSK CD48- CD150+ CD34+ cells would result in 
engraftment at least when injected IF, 45 instead of 15 of these cells were injected (Table 
1 ). No contrai transplantations were performed during this second experiment, but 2 mice 
each were injected or not with rescue BM after total body irradiation. As only those that 
received rescue BM survived, total body irradiation was most likely efficient while HSC 
depletion within the rescue BM was probably not absolute (data not shown). 
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Figure 2. FACS plots illustrating the analysis of peripheral granulocyte chimerism. (A) Total events and the 
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gates are shown for a mouse displaying no chimerism (C, D) and for a mouse displaying chimerism (E, F) . 
Events displayed on the left side (C, E) are pre-gated on WBCs, those displayed on the right side (D, F) are 
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known to partially cross-react with CD45.1. 
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chimeric IF-injected (B; N=3) and IV-injected mice (C; N=2). 
Unfortunately, the second experiment did not show the anticipated results: Not only were 
the results in most cases even more variable and the error bars thus even bigger, but most 
mice showed diminishing chimerism over time, and, although high CD45.1 + peripheral 
granulocyte frequencies were observed (especially for one individual) in the subgroup of 
mice injected IV with LSK CD48- CD150+ co34- cells (chimerism in 5 (80%) of 6 mice), 
they were substantially lower for the mice injected IF with the same cells (chimerism in 3 
(50%) of 6 mice) (Figure 4). Finally, to our surprise and inconsistent with what has been 
published previously, IV injection of LSK CD48- CD150+ CD34+ cells resulted in significant 
chimerism (chimerism in 3 (60%) of 5 mice), whereas no engraftment was observed in the 
mice injected IF (Figure 4 ). 
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Side Population Phenotype of Different HSC Subsets 
To assess the SP phenotype of different BM cell and, in particular, of putative HSC 
subsets, 8-colour FACS analyses were performed using Hoechst 33342 and antibody 
staining in parallel. The results presented below, with exception of the verapamil contrai, 
were collected during the same experiment, which was representative of numerous 
experiments done with slightly differing experimental conditions. 
The same antigenic markers as described above were used to define different BM 
subsets. The gating strategy is illustrated in Figure 5. Lineage-depleted cells, pre-gated on 
single Pl-negative cells, were gated on LSK and divided into further subsets , according to 
the surface expression of CD48, CD150 and CD34. 
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SP activity was assessed by displaying Hoechst fluorescent events (previously gated on 
single Pl-negative cells) simultaneously at two different emission wavelengths (Hoechst 
red versus blue), as previously reported. 24 Figure 6 illustrates the SP and its inhibition 
upon addition of verapamil, a patent inhibitor of ABC transporters, during incubation with 
Hoechst 33342.24 45 
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Figure 6. FACS dot plots 
showing an SP and its 
suppression upon concomitant 
treatment with verapamil. Non-
lineage-depleted BM cells were 
incubated for 90 minutes at 
37°C either with Hoechst 33342 
alone (A) or with Hoechst 33342 
and verapamil (8) . Cells are pre-
gated on single Pl-negative 
cells . 300'000 events are 
displayed per plot. 
To examine whether the cells within the tip of the SP contain a higher proportion of cells 
with a putatively dormant phenotype than the total SP, an "SP tip" gate was defined in 
addition to the total SP gate (Figure 7). 17 
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Figure 7. Definition of "SP" (A) and "SP tip" (B) gates. 
Next, to examine SP and SP tip profiles of different BM cell subsets, the latter, as defined 
in Figure 5, were plotted on Hoechst red versus blue plots (Figure 8). Quantitative analysis 
of these profiles (Figure 9) shows similar findings for both the SP and SP tip gates, 
although the proportions are approximately 1 Ox smaller for the latter. The following 
discussion will therefore concentrate on the SP gate only. Within LSK cells, only CD48-
cells seem to have a significant proportion within the SP (Figures 8C, BE & 9). This 
proportion is particularly impressive for the CD48- CD150+ fraction (14.6%) but is also 
surprisingly high for the CD48- CD150- fraction (6.4% ). If the SP profile is really to reflect 
long-term reconstitution ability, this finding would suggest that the latter is not limited to the 
CD48- CD150+ fraction but also concerns CD48- CD150- cells and that CD150 might not 
be such a distinctive marker in terms of reconstitution ability as suggested by the authors 
who first reported it as an HSC antigenic marker. 16 lnterestingly, recent findings indeed 
confirm this impression by showing that the LSK SP CD150- compartment contains a 
substantial fraction of cells capable of long-term reconstitution. The identification of HSCs 
on the basis of SLAM markers was thus suggested to neglect an important fraction of long-
term HSCs. 36 
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Hoechst Red 
Figure 8. Hoechst plots showing SP and SP tip profiles of different BM cell subsets as defined in Figure 5. 
Ali events are pre-gated on single Pl-negative cells . The events in G and H are gated on those shown in C. 
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on single Pl-negative cells (data based on Figure 8). 
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Finally, within the LSK CD48- CD150+ subset, co34- cells constitute a much higher 
proportion of SP cells than CD34+ cells (35.6% vs. 7.8%; see Figures 8G, 8H & 9), 
suggesting a substantial enrichment for LSK CD48- CD150+ CD34-, the supposedly most 
dormant HSCs, within the SP. As already hinted above, however, no additional enrichment 
was found within the cells responsible for formation of the SP tip gate. 
Subsequently, we analysed the data the other way round, by examining the antigenic 
marker profile of SP cells. BM cells were pre-gated on single Pl-negative cells, as in Figure 
5, and then further gated on SP cells. These were then plotted using the same gating 
cascade as presented above, allowing us to calculate the fraction of SP cells belonging to 
the different BM cell subsets (Figures 10 & 11 ). Due to very low numbers, the 
corresponding analyses for SP tip cells was not very informative (data not shown). 
ln comparison with total single Pl- cells , relatively high fractions of SP cells were found to 
be located within the Lin- (88.5%), the LSK (31.4%) and the LSK CD48- CD150+ subsets 
(20.2% ), especially within the co34- fraction of the latter (12.1 % versus 8.1 % for the 
CD34+ fraction) (Figure 11 ), implying a significant enrichment for SP cells within these 
subsets. 
lt has been suggested that SP LSK (also known as "SParKLS") cells may represent a 
subset of cells very highly enriched for long-term HSCs.26 45 Figure 1 OG indeed somewhat 
favours such an hypothesis by showing that a majority (64.2%) of SP LSK cells are 
simultaneously CD48- and CD150+. Within the SP LSK cells, approximately 50% are 
co34- (data not shown). 
The profiles in Figure 10, however, also suggest that there is some overlap between the 
SP phenotype and expression of some of the antigenic HSC markers, especially those 
responsible for defining the LSK subset. As such, after the exclusion of doublets and dead 
cells, SP gating of lineage-depleted cells may allow for a significant enrichment for HSCs 
without the need to use, for example, lineage markers, cKit or perhaps even CD150 (the 
validity of which as an HSC marker has already been questioned above, independently of 
SP gating). 
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Figure 1 O. HSC antigenic marker 
profiles of SP cells . Cells were pre-
gated either on single Pl-negative 
cells only (left side, A-D) or, 
additionally, on SP (right side , E-H). 
Plots A-D are identical to plots C-F 
in Figure 5. The same gating 
strategy was used as presented in 
Figure 5, with each plot displaying 
only events defined by the gate 
annotated in the plot immediately 
above. FSC, forward scatter; Aix, 
Alexa . 
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lndeed, if SP-forming cells are more stringently gated according to Sca1 and CD48 
expression than done above, in that only very high Sca1-expressing and very low CD48-
expressing cells are selected (Figure 12), this new subset of BM cells (singles / Pl-/ SP / 
Sca1very high / CD48very 10w) is extremely enriched for Lin- cells (99%), cKit+ cells (93%) and 
even CD150 (86%) (Figure 13). Within this subset, 63% are CD34-(Figure 13) . 
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DISCUSSION 
The first successful enrichment for HSC activity from total mouse BM was reported in 
1988, having been achieved by sorting cells previously stained with fluorescence-coupled 
antibodies against surface markers.46 ln the last 20 years, this pioneering work was refined 
by a number of laboratories, and, in the meantime, the strategies to enrich for putative 
HSC activity are plentiful, each laboratory having its favourite one(s).8 14 19 47 Although the 
different approaches result in significantly overlapping populations, there are also some 
differences, and, therefore, this wealth of strategies can be problematic when attempting to 
compare different publications involving the isolation of HSCs. 
As such, the choice of surface markers we used for the presented research also reflects, 
to some extent, the history within our laboratory, and, although they are well-established 
mouse HSC markers, it should be kept in minci that they are not the only ones. Other 
commonly used mouse HSC markers include Thy1 .1 48 (which is strain-specific) and Flk-
249, the absence or low expression of which excludes not only fully differentiated cells but 
also more committed progenitors, just as is said to be the case for the Lin markers and 
CD34. Furthermore, Tie-233 and endoglin50 are other examples of markers expressed at 
high levels on the surface of HSCs, and, finally, CD24416 is another SLAM family member 
that seems to be absent on HSCs and can be used for negative selection, similar to CD48. 
Long-Term Reconstitution Ability of Different HSC Subsets 
As outlined above, one of the aims of this study was to test whether functional HSCs are 
indeed co34- or whether this is only a requirement for homing of HSCs to their niche after 
IV transplantation, which is typically used in the L TR assay. We therefore attempted to 
transplant putative HSCs directly into their physiological niche by IF injection. This 
transplantation technique was recently used to identify a new class of human HSCs, 
capable of more rapid multi-lineage and long-term reconstitution in the severe combined 
immunodeficiency (SCID) repopulating (SRC) xenotransplant assay than contrai HSCs 
injected IV.11 
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We used sorted LSK CD48- CD150+ co34- cells as a positive (HSC) contrai for both IV 
and IF injections and LSK CD48+ CD150- CD34+ as a negative contrai. LSK CD48-
CD150+ CD34+ represented the actual "test" cells: We wanted to examine their ability to 
engraft, as assessed by long-term analysis of peripheral granulocyte chimerism, when 
injected IF, in contrast to when injected IV. 
Both contrais from the first experiment presented above (Figure 3) seem to have worked 
as anticipated: The negative contral-injected cells were unable to engraft, although the 
recipient mice survived even at long-term, which may be explained by insufficient HSC 
depletion of the rescue BM (see above). The LSK CD48- CD150+ co34- (positive HSC 
contrai) cell-injected mice engrafted both IV and IF, and, moreover, IF transplantation 
resulted in more rapid and more effective engraftment than IV transplantation, consistent 
with what has been reported for the human SRC assay. 11 LSK CD48- CD150+ CD34+ 
cells, however, were unable to engraft whether IF nor IV, thus providing no evidence for 
the validity of our hypothesis that CD34 surface expression specifically interferes with 
homing of putative HSCs to the BM. 
Regrettably, as illustrated above (Figure 4 ), the second experiment did not provide any 
conclusive results. The higher frequency of donor granulocytes within the positive contrai 
IV-injected subgroup as compared to the first experiment may be explained by a slightly 
delayed administration of more efficiently HSC-depleted rescue BM (see materials & 
methods). The pattern of results, however, is rather puzzling and leaves us with the 
unanswered question as to how well the staining and/or sorting of the donor cells actually 
worked during this experiment. 
Given the low numbers and therefore only preliminary results of the first and the non-
conclusive results of the second experiment, it is, at this point, impossible to definitely 
confirm or reject our initial hypothesis. ln order to obtain more conclusive results, more 
L TR assays would have to be performed. However, in neither of the experiments were IF-
injected LSK CD48+ CD150- CD34+ cells able to engraft, and, therefore, we think it is 
unlikely that they would do so in an additional experiment using the same conditions. 
Regarding the deaths reported in Table 2, it is worth noticing that, summarising the two 
experiments, 24% of IF-injected mice died within the first 15 days, in contrast to only 8% of 
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the IV-injected ones, suggesting that injecting mice IF is more traumatic. This may be due 
a combination of the trauma itself, of trauma-related haemorrhage, of administration of 
morphinic analgesia before and of the general anaesthesia used during the procedure. 
lt should be mentioned that CD34 expression on mouse HSCs has been discussed in a 
rather controversial manner in recent years. Not only is there compelling evidence that, in 
contrast to the dormant ones, activated HSCs are CD34+ (see above), but, moreover, 
CD34 surface expression also seems to undergo changes during development. HSCs 
within the mouse foetus and till at least 5 weeks of age have been reported to be 
exclusively CD34+, and only from 7 weeks of age has long-term HSC activity been 
reported within the CD34- fraction of BM cells.51 -53 This situation, however, as it occurs in 
unborn and young mi ce, seems reversed in the a duit mouse - from 10 weeks of age 
onwards, the majority of HSCs are CD34-.53 Finally, it has even been suggested that the 
observed exclusivity of long-term HSC activity within the LSK co34- subset is an artefact 
of the lineage-negative enrichment protocol used prior to cell sorting.54 ln fact, some 
limited HSC activity was indeed previously documented within the Lin- fraction of cells, 55 
and more recent evidence even explicitly suggests that lineage depletion may 
inadvertently discard important populations of CD34+ HSCs.56 At the same time, however, 
sorting even just the number of cells required for the experiments presented in this study 
justifies an enrichment protocol, as the frequency of the studied cell phenotypes would be 
much too low and the sorting procedure would take by far too much time in its absence. 
The last comment on the L TR assays concerns the follow-up studies of the recipient mice 
after transplantation. We are totally aware that analysis of peripheral granulocyte 
chimerism is clearly not sufficient to prove multi-lineage and long-term engraftment ability 
of the transplanted cells, but that a more detailed analysis of donor-derived haematopoietic 
contribution within the recipient mice (by analysis of the stem and progenitor cell pool as 
well as of multiple lineages) and even serial transplantations would be necessary to 
achieve this goal. Given our preliminary and partially contradicting results, however, we 
believe that further long-term and costly analysis at this point was not going to lead to any 
more conclusive results. 
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Side Population Phenotype of Different HSC Subsets 
As mentioned above, some widely used approaches to enrich for HSC activity rely on 
alleged functional properties of HSCs such as the capacity to exclude the fluorescent dye 
Hoechst 33342 and to form an SP on a Hoechst red versus blue bivariate FACS plot. 
Given the confirmed correlation between long-term HSC activity and SP activity, one could 
even consider using the latter as a preliminary functional test for HSCs. Therefore, we set 
out to perform 8-colour FACS analyses, comparing the various BM cell subsets described 
above with their ability to form an SP and thereby also attempting to examine the overlap 
between different currently used methods to isolate putative HSCs. 
As discussed above, this approach indeed allowed us to validate some of the markers 
commonly used to isolate HSCs, but, simultaneously, it also led us to question others. 
Moreover, it prompted us to propose a new HSC isolation strategy (SP / Sca1 very high ! 
CD48very 10w) that might lead to similar or even better reconstitution efficiencies than the 
ones achieved so far, while enabling the use of substantially less antibodies and thus 
allowing HSC isolation by less complicated FACS experiments. This result being only very 
preliminary, however, this hypothesis obviously needs confirmation by assaying 
reconstitution activity in vivo. 
Furthermore, within the LSK CD48- CD150+ fraction, there seems to be a significantly 
higher correlation between the SP and co34- cells than between the SP and CD34+ cells. 
Considering the idea that ABC transporters are thought to protect normal and cancer stem 
cells by preventing intracellular accumulation of toxic compounds, 57 it seems plausible 
that, the more undifferentiated and dormant a stem cell is, the more protection it might 
need and the more active its transporters might be. As such, the above correlation is 
indeed consistent with the hypothesis that co34- cells are more primitive and/or dormant 
than CD34+ cells. lnterestingly, it has been reported that this correlation is even more 
significant if mice aged below 10 weeks are used. 26 This observation may be due to 
differential CD34 expression during development (see above), but may also be related to 
the tact that the SP phenotype seems to vary quite dramatically between BM cell samples 
of mice of different ages.58 59 
34 
At this point, it should be reminded that the SP technique does have some caveats. Firstly, 
although there are undeniably significant correlations, in terms of HSC surface marker 
expression, SP cells seem to be very heterogeneous. For example, only 30% of SP cells 
belong to the LSK subset (Figure 11 ). This heterogeneity could be partly explained by the 
tact that the SP phenotype does most likely not just depend on dye efflux but also on 
uptake, the kinetics of which is probably entirely unrelated to the ability of SP cells to act 
as stem cells. 60 
A major problem of the Hoechst 33342 dye is its significant toxicity.30 61 62 lt has even been 
suggested that the cells that stain poorly ( either because they have not imported or 
because they have exported the taxie dye) display a higher reconstitution capacity 
because they remain more viable and therefore more functional than the remainder of the 
cells. 63 Although this is vividly discussed at conferences, to our knowledge, so far, no in 
vivo data clearly addresses and obliterates these concerns. An alternative, therefore, when 
aiming at transplanting cells isolated on the basis of their SP phenotype, is to use other, 
less taxie dyes such as the mitochondria-binding dye rhodamine-123.64 
Furthermore, the requirement of an (expensive) UV laser for SP analysis using Hoechst 
33342 increases the urge to look for alternative dyes. ln this context, one group recently 
reported the successful use of DyeCycle Violet (DCV) as a replacement for Hoechst 33342 
on instruments with violet lasers.65 
Finally, as mentioned above, an important issue in stem cell biology (but not only) is the 
reproducibility of results. The SP technique has indeed shown certain limitations due to the 
difficulty to produce comparable results in different laboratories - not only is the technique 
extremely delicate and sensitive to the slightest changes in the experimental conditions, 
but it also requires rather advanced FACS instrumentation knowhow. Following precisely a 
well-established protocol is therefore primordial when working with the SP technique. 
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CONCLUSION & OUTLOOK 
ln this study, we first analyse the ability of different HSC subsets to reconstitute lethally 
irradiated mice, when injected either IV or IF. Although the results from our L TR assays 
using LSK CD48- CD150+ CD34- cells support the idea that IF transplantation leads to 
faster and more effective engraftment than IV transplantation, we are unable to show that 
LSK CD48- CD150+ CD34+ cells are capable of engrafting specifically when injected IF. 
We therefore believe that our initial hypothesis - that CD34 expression on IV injected 
donor BM cells specifically hampers their homing to the recipient BM - is unlikely to be 
true. However, given the preliminary nature of our results, definite rejection of our 
hypothesis would require additional L TR assays. 
Secondly, we compare the relative SP activity of different BM cell subsets, as defined by 
their expression profile of the above antigenic markers. The results of our flow cytometric 
analyses prompt us to question some of the markers commonly used to isolate mouse BM 
HSCs ex vivo and to propose a simplified new enrichment strategy. We suggest that SP 
Sca1very high CD48very low cells might lead to similar or even better reconstitution efficiencies 
than the ones achieved so far with more complicated purification schemes. lt will therefore 
be interesting to test the in vivo functional capacity of these cells using L TR assays. 
36 
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